PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

(-)-α-Bisabolol reduces nociception and trigeminal central sensitisation in acute orofacial neuropathic pain induced by infraorbital nerve injury.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31002923 ↗2019Reported benefit

(-)-α-Bisabolol reduces nociception and trigeminal central sensitisation in acute orofacial neuropathic pain induced by infraorbital nerve injury.

RatOtherSprague-Dawleymalen = n = 8 per group for behavioural testingoral (per oris)200 mg/kgadministered at post-operative day 7 after infraorbital nerve transection

Model: Infraorbital nerve transection (IONX), trigeminal neuropathic pain

Infraorbital nerve transection produced facial mechanical hypersensitivity unaffected by vehicle. Bisabolol 200 mg/kg orally significantly reversed the mechanical hypersensitivity for at least 6 h and reversed central sensitisation of medullary dorsal horn nociceptive neurons, restoring activation…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.